Ledger.Open graph →
SEC Form D · filed January 30, 2026

Navega Therapeutics, Inc

Offering
$2.5M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Randy Socol · San Diego, CAExecFernando Aleman · San Diego, CAExec · DirectorAna Moreno · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗